These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28610482)

  • 1. Randomised controlled trial of a healthy lifestyle intervention among smokers with psychotic disorders: Outcomes to 36 months.
    Baker AL; Richmond R; Kay-Lambkin FJ; Filia SL; Castle D; Williams JM; Lewin TJ; Clark V; Callister R; Palazzi K
    Aust N Z J Psychiatry; 2018 Mar; 52(3):239-252. PubMed ID: 28610482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized Controlled Trial of a Healthy Lifestyle Intervention Among Smokers With Psychotic Disorders.
    Baker AL; Richmond R; Kay-Lambkin FJ; Filia SL; Castle D; Williams JM; Lewin TJ; Clark V; Callister R; Weaver N
    Nicotine Tob Res; 2015 Aug; 17(8):946-54. PubMed ID: 25744962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial of a smoking cessation intervention among people with a psychotic disorder.
    Baker A; Richmond R; Haile M; Lewin TJ; Carr VJ; Taylor RL; Jansons S; Wilhelm K
    Am J Psychiatry; 2006 Nov; 163(11):1934-42. PubMed ID: 17074945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healthy recovery: A stepped wedge cluster randomised controlled trial of a healthy lifestyle intervention for people attending residential alcohol and other drug treatment.
    Kelly PJ; Baker AL; Deane FP; Callister R; Collins CE; Oldmeadow C; Palazzi KL; Townsend CJ; Ingram I; Keane CA; Penning A; Hazelton JL; Beck AK
    Drug Alcohol Depend; 2021 Apr; 221():108557. PubMed ID: 33714901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-Reported Reasons for Smoking: Predicting Abstinence and Implications for Smoking Cessation Treatments Among Those With a Psychotic Disorder.
    Clark V; Baker A; Lewin T; Richmond R; Kay-Lambkin F; Filia S; Castle D; Williams J; Todd J
    J Dual Diagn; 2017; 13(1):6-14. PubMed ID: 27982748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between clinical and psychosocial factors and metabolic and cardiovascular risk factors in overweight patients with schizophrenia spectrum disorders - Baseline and two-years findings from the CHANGE trial.
    Storch Jakobsen A; Speyer H; Nørgaard HCB; Hjorthøj C; Krogh J; Mors O; Nordentoft M
    Schizophr Res; 2018 Sep; 199():96-102. PubMed ID: 29501386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the effectiveness of a healthy lifestyle clinician in addressing the chronic disease risk behaviours of community mental health clients: study protocol for a randomised controlled trial.
    Fehily C; Bartlem K; Wiggers J; Wye P; Clancy R; Castle D; Wutzke S; Rissel C; Wilson A; McCombie P; Murphy F; Bowman J
    Trials; 2017 Jun; 18(1):276. PubMed ID: 28619025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary patterns and physical activity in people with schizophrenia and increased waist circumference.
    Jakobsen AS; Speyer H; Nørgaard HCB; Karlsen M; Hjorthøj C; Krogh J; Mors O; Nordentoft M; Toft U
    Schizophr Res; 2018 Sep; 199():109-115. PubMed ID: 29555213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varenicline plus healthy lifestyle intervention for smoking cessation in psychotic disorders.
    Castle D; Baker AL; Richmond R; Filia SL; Harris D; Pirola-Merlo AJ
    Ann Clin Psychiatry; 2012 Nov; 24(4):285-91. PubMed ID: 23145385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A two-site, two-arm, 34-week, double-blind, parallel-group, randomized controlled trial of reduced nicotine cigarettes in smokers with mood and/or anxiety disorders: trial design and protocol.
    Allen SI; Foulds J; Pachas GN; Veldheer S; Cather C; Azzouz N; Hrabovsky S; Hameed A; Yingst J; Hammett E; Modesto J; Krebs NM; Zhu J; Liao J; Muscat JE; Richie J; Evins AE
    BMC Public Health; 2017 Jan; 17(1):100. PubMed ID: 28103841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a universal smoking cessation intervention initiated in inpatient psychiatry and continued post-discharge: A randomised controlled trial.
    Metse AP; Wiggers J; Wye P; Wolfenden L; Freund M; Clancy R; Stockings E; Terry M; Allan J; Colyvas K; Prochaska JJ; Bowman JA
    Aust N Z J Psychiatry; 2017 Apr; 51(4):366-381. PubMed ID: 28195010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cigarette smoking and psychosis: naturalistic follow up 4 years after an intervention trial.
    Baker A; Richmond R; Lewin TJ; Kay-Lambkin F
    Aust N Z J Psychiatry; 2010 Apr; 44(4):342-50. PubMed ID: 20307166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceptance and Commitment Therapy and nicotine patch for smokers with bipolar disorder: preliminary evaluation of in-person and telephone-delivered treatment.
    Heffner JL; McClure JB; Mull KE; Anthenelli RM; Bricker JB
    Bipolar Disord; 2015 Aug; 17(5):560-6. PubMed ID: 25912192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative and cost effectiveness of telemedicine versus telephone counseling for smoking cessation.
    Richter KP; Shireman TI; Ellerbeck EF; Cupertino AP; Catley D; Cox LS; Preacher KJ; Spaulding R; Mussulman LM; Nazir N; Hunt JJ; Lambart L
    J Med Internet Res; 2015 May; 17(5):e113. PubMed ID: 25956257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of an intensive smoking cessation intervention on disease activity in patients with rheumatoid arthritis: study protocol for a randomised controlled trial.
    Roelsgaard IK; Thomsen T; Østergaard M; Christensen R; Hetland ML; Jacobsen S; Andersen L; Tønnesen H; Rollefstad S; Semb AG; Esbensen BA
    Trials; 2017 Nov; 18(1):570. PubMed ID: 29183347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'Better Health Choices' by telephone: a feasibility trial of improving diet and physical activity in people diagnosed with psychotic disorders.
    Baker AL; Turner A; Kelly PJ; Spring B; Callister R; Collins CE; Woodcock KL; Kay-Lambkin FJ; Devir H; Lewin TJ
    Psychiatry Res; 2014 Dec; 220(1-2):63-70. PubMed ID: 25078563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and cost-effectiveness of an intervention for reducing cholesterol and cardiovascular risk for people with severe mental illness in English primary care: a cluster randomised controlled trial.
    Osborn D; Burton A; Hunter R; Marston L; Atkins L; Barnes T; Blackburn R; Craig T; Gilbert H; Heinkel S; Holt R; King M; Michie S; Morris R; Morris S; Nazareth I; Omar R; Petersen I; Peveler R; Pinfold V; Walters K
    Lancet Psychiatry; 2018 Feb; 5(2):145-154. PubMed ID: 29396118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychological distress following a motor vehicle crash: preliminary results of a randomised controlled trial investigating brief psychological interventions.
    Guest R; Tran Y; Gopinath B; Cameron ID; Craig A
    Trials; 2018 Jun; 19(1):343. PubMed ID: 29945650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary heart disease risk reduction intervention among overweight smokers with a psychotic disorder: pilot trial.
    Baker A; Richmond R; Castle D; Kulkarni J; Kay-Lambkin F; Sakrouge R; Filia S; Lewin TJ
    Aust N Z J Psychiatry; 2009 Feb; 43(2):129-35. PubMed ID: 19153920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study protocol: a randomised controlled trial investigating the effect of a healthy lifestyle intervention for people with severe mental disorders.
    Baker A; Kay-Lambkin FJ; Richmond R; Filia S; Castle D; Williams J; Lewin TJ
    BMC Public Health; 2011 Jan; 11(1):10. PubMed ID: 21208433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.